| ［1］ |
Boniface K, Jacquemin C, Darrigade A S, et al. Vitiligo skin is imprinted with resident memory CD8 T cells expressing CXCR3 ［J］. J Invest Dermatol, 2018,138（2）:355⁃364. doi: 10.1016/j.jid.2017.08.038.
|
| ［2］ |
Chen L, Shen Z. Tissue⁃resident memory T cells and their biological characteristics in the recurrence of inflammatory skin disorders［J］. Cell Mol Immunol, 2020,17（1）:64⁃75. doi: 10. 1038/s41423⁃019⁃0291⁃4.
|
| ［3］ |
Cheuk S, Schlums H, Gallais Sérézal I, et al. CD49a expression defines tissue⁃resident CD8（+） T cells poised for cytotoxic function in human skin［J］. Immunity, 2017,46（2）:287⁃300. doi: 10.1016/j.immuni.2017.01.009.
|
| ［4］ |
Kurihara K, Fujiyama T, Phadungsaksawasdi P, et al. Signifi⁃cance of IL⁃17A⁃producing CD8（+）CD103（+） skin resident memory T cells in psoriasis lesion and their possible relationship to clinical course［J］. J Dermatol Sci, 2019,95（1）:21⁃27. doi: 10.1016/j.jdermsci.2019.06.002.
|
| ［5］ |
Lee Y J, Park J A, Kwon H, et al. Role of stem cell⁃like memory T cells in systemic lupus erythematosus［J］. Arthritis Rheumatol, 2018,70（9）:1459⁃1469. doi: 10.1002/art.40524.
|
| ［6］ |
Fazeli P, Talepoor AG, Faghih Z, et al. The frequency of CD4+ and CD8+ circulating T stem cell memory in type 1 diabetes［J］. Immun Inflamm Dis, 2022,10（10）:e715. doi: 10.1002/iid3.715.
|
| ［7］ |
Ryan GE, Harris JE, Richmond JM. Resident memory T cells in autoimmune skin diseases［J］. Front Immunol, 2021,12:652191. doi: 10.3389/fimmu.2021.652191.
|
| ［8］ |
Hosokawa K, Muranski P, Feng X, et al. Memory stem T cells in autoimmune disease: high frequency of circulating CD8+ memory stem cells in acquired aplastic anemia ［J］. J Immunol, 2016,196（4）:1568⁃1578.doi:10.4049/jimmunol.1501739.
|
| ［9］ |
Hadi A, Wang JF, Uppal P, et al. Comorbid diseases of vitiligo: a 10⁃year cross⁃sectional retrospective study of an urban US population［J］. J Am Acad Dermatol, 2020,82（3）:628⁃633. doi: 10.1016/j.jaad.2019.07.036.
|
| ［10］ |
Lin F, Sun X, Lei J, et al. Altered circulating memory T cells in vitiligo cases followed NB⁃UVB therapy［J］. Photodermatol Photoimmunol Photomed, 2022,38（1）:76⁃82. doi: 10.1111/phpp. 12719.
|
| ［11］ |
Martins C, Darrigade AS, Jacquemin C, et al. Phenotype and function of circulating memory T cells in human vitiligo［J］. Br J Dermatol, 2020,183（5）:899⁃908. doi: 10.1111/bjd.18902.
|
| ［12］ |
Fujiyama T, Umayahara T, Kurihara K, et al. Skin infiltration of pathogenic migratory and resident T cells is decreased by secukinumab treatment in psoriasis［J］. J Invest Dermatol, 2020,140（10）:2073⁃2076.e6. doi: 10.1016/j.jid.2020.02.024.
|
| ［13］ |
Kasprowicz⁃Furmańczyk M, Czerwińska J, Placek W, et al. Assessment of the tissue resident memory cells in lesional skin of patients with psoriasis and in healthy skin of healthy volunteers［J］. Int J Environ Res Public Health, 2021,18（21）doi: 10.3390/ijerph182111251.
|
| ［14］ |
Phadungsaksawasdi P, Fujiyama T, Kurihara K, et al. PD⁃1 expression defines epidermal CD8（+）CD103（+） T cells preferentially producing IL⁃17A and using skewed TCR repertoire in psoriasis［J］. J Invest Dermatol, 2021,141（10）:2426⁃2435.e5. doi: 10.1016/j.jid.2021.03.011.
|
| ［15］ |
Suzuki K, Suzuki K, Yabe Y, et al. NF⁃κB1 contributes to imiquimod⁃induced psoriasis⁃like skin inflammation by inducing Vγ4（+）Vδ4（+）γδT17 cells［J］. J Invest Dermatol, 2022,142（6）:1639⁃1649.e5. doi: 10.1016/j.jid.2021.11.004.
|
| ［16］ |
Zhao Z, Zhu H, Li Q, et al. Skin CD4（+） Trm cells distinguish acute cutaneous lupus erythematosus from localized discoid lupus erythematosus/subacute cutaneous lupus erythematosus and other skin diseases［J］. J Autoimmun, 2022,128:102811. doi: 10.1016/j.jaut.2022.102811.
|
| ［17］ |
Gu HJ, Song S, Roh JY, et al. Expression pattern of tissue⁃resident memory T cells in cutaneous lupus erythematosus［J］. Lupus, 2021,30（9）:1427⁃1437. doi: 10.1177/09612033211017218.
|
| ［18］ |
袁祥, 周滢波, 王其凯,等. 系统性红斑狼疮组织原位记忆T细胞表达与皮损相关性研究［J］. 中华风湿病学杂志, 2017,21（10）:680⁃684,722. doi: 10.3760/cma.j.issn.1007⁃7480.2017.10. 007.
|
| ［19］ |
Chen X, Guo W, Chang Y, et al. Oxidative stress⁃induced IL⁃15 trans⁃presentation in keratinocytes contributes to CD8（+） T cells activation via JAK⁃STAT pathway in vitiligo［J］. Free Radic Biol Med, 2019,139:80⁃91. doi: 10.1016/j.freeradbiomed. 2019.05.011.
|
| ［20］ |
Richmond JM, Strassner JP, Zapata L, et al. Antibody blockade of IL⁃15 signaling has the potential to durably reverse vitiligo［J］. Sci Transl Med, 2018,10（450）:eaan7710. doi: 10.1126/scitranslmed.aam7710.
|
| ［21］ |
Martins C, Migayron L, Drullion C, et al. Vitiligo skin T cells are prone to produce type 1 and type 2 cytokines to induce melanocyte dysfunction and epidermal inflammatory response through Jak signaling［J］. J Invest Dermatol, 2022,142（4）:1194⁃1205.e7. doi: 10.1016/j.jid.2021.09.015.
|
| ［22］ |
Azzolino V, Zapata L Jr, Garg M, et al. Jak inhibitors reverse vitiligo in mice but do not deplete skin resident memory T cells［J］. J Invest Dermatol, 2021,141（1）:182⁃184.e1. doi: 10.1016/j.jid.2020.04.027.
|
| ［23］ |
Song H, Hu Z, Zhang S, et al. Effectiveness and safety of tofacitinib combined with narrowband ultraviolet B phototherapy for patients with refractory vitiligo in real⁃world clinical practice［J］. Dermatol Ther, 2022,35（11）:e15821. doi: 10.1111/dth.15821.
|
| ［24］ |
Mehta H, Mashiko S, Angsana J, et al. Differential changes in inflammatory mononuclear phagocyte and T⁃cell profiles within psoriatic skin during treatment with guselkumab vs. secukinumab［J］. J Invest Dermatol, 2021,141（7）:1707⁃1718.e9. doi: 10. 1016/j.jid.2021.01.005.
|
| ［25］ |
Chen Y, Yan Y, Liu H, et al. Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8（+） T⁃cell memory in wild⁃type and humanized mice［J］. Theranostics, 2020,10（23）:10466⁃10482. doi: 10.7150/thno.45211.
|
| ［26］ |
Pan Y, Tian T, Park C O, et al. Survival of tissue⁃resident memory T cells requires exogenous lipid uptake and metabolism ［J］. Nature, 2017,543（7644）:252⁃256. doi: 10.1038/nature21379.
|
